Travere Therapeutics (TVTX) Return on Capital Employed Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 4,406.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,406.00 |
| Dec 31, 2025 | 4,214.00 |
| Sep 30, 2025 | 2,901.00 |
| Jun 30, 2025 | -820.00 |
| Mar 31, 2025 | -2,565.00 |
| Dec 31, 2024 | -6,232.00 |
| Sep 30, 2024 | -6,981.00 |
| Jun 30, 2024 | -4,747.00 |
| Mar 31, 2024 | -4,303.00 |
| Dec 31, 2023 | -2,970.00 |
| Sep 30, 2023 | -4,493.00 |
| Jun 30, 2023 | -4,009.00 |
| Mar 31, 2023 | -3,469.00 |
| Dec 31, 2022 | -3,066.00 |
| Sep 30, 2022 | -3,009.00 |
| Jun 30, 2022 | -1,897.00 |
| Mar 31, 2022 | -1,560.00 |
| Dec 31, 2021 | -1,743.00 |
| Sep 30, 2021 | -1,808.00 |
| Jun 30, 2021 | -1,691.00 |
| Mar 31, 2021 | -2,211.00 |
| Dec 31, 2020 | -1,924.00 |
| Sep 30, 2020 | -84.00 |
| Jun 30, 2020 | -261.00 |
| Mar 31, 2020 | -734.00 |
| Dec 31, 2019 | -1,367.00 |
| Sep 30, 2019 | -870.00 |
| Jun 30, 2019 | -778.00 |
| Mar 31, 2019 | -569.00 |
| Dec 31, 2018 | -122.00 |
| Sep 30, 2018 | -311.00 |
| Jun 30, 2018 | 578.00 |
| Mar 31, 2018 | 2,532.00 |
| Dec 31, 2017 | 22,829.00 |
| Dec 31, 2016 | -16,747.00 |
| Mar 31, 2016 | 16,749.00 |